Omeprazole capsules Clinical Trials

• Rectal and Oral Omeprazole Treatment of Reflux Disease in Infants.
  ClinicalTrials.gov Identifier: NCT00226044 - Recruiting
  Gastroesophageal Reflux; Esophageal Atresia; Hernia, Diaphragmatic
  
• Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
  ClinicalTrials.gov Identifier: NCT00141102 - Recruiting
  Osteoarthritis; Arthritis, Rheumatoid
  
• Omeprazole and Amoxicillin and/or Vitamin and Mineral Supplements and/or Garlic Supplements in Preventing Stomach Cancer in Patients With Precancerous Stomach Lesions
  ClinicalTrials.gov Identifier: NCT00134121 - Active, not recruiting
  Gastric Cancer; Precancerous Condition
  
• A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
  ClinicalTrials.gov Identifier: NCT00251030 - Completed
  
  
• Evaluation of efficacy, safety and tolerability of Targretin capsules in patients with advanced or metastatic non-small cell lung cancer
  ClinicalTrials.gov Identifier: NCT00050960 - Active, not recruiting
  Non-small cell lung cancer
  
• Influence Of Omeprazole On The Anti-Platelet Action Of Clopidogrel
  ClinicalTrials.gov Identifier: NCT00349661 - Recruiting
  Coronary Heart Disease
  
• Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.
  ClinicalTrials.gov Identifier: NCT00298779 - Active, not recruiting
  Tumors; Non-Hodgkins's Lymphoma
  
• Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00420615 - Recruiting
  Solid Tumors
  
• An Open-Label, Randomized, Comparative 3-Way Cross-Over Study to Evaluate the Effect of Food on the 24-Hour Intragastric pH at Day 5 After Twice Daily Oral Administration of PN 200 (Omeprazole/Naproxen) in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00442208 - Active, not recruiting
  Healthy
  
• Pharmacokinetics of Enteral Omeprazole Suspension in Patients With Cerebral Palsy and Mental Retardation
  ClinicalTrials.gov Identifier: NCT00426595 - Recruiting
  Gastreoesophageal Reflux Disease
  
• Omeprazole and Bortezomib in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00107302 - Recruiting
  adult lymphomatoid granulomatosis; adult non-Hodgkin's lymphoma; adult solid tumor; indolent or aggressive adult non-Hodgkin's lymphoma
  
• Omeprazole and Reflux Disease - Improvement of Clinical Outcome by Genotype-Adjusted Dosing
  ClinicalTrials.gov Identifier: NCT00537732 - Recruiting
  Gastroesophageal Reflux
  
• Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
  ClinicalTrials.gov Identifier: NCT00402259 - Recruiting
  Gastrointestinal Hemorrhage
  
• Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
  stage I gastric cancer
  
• Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00388882 - Active, not recruiting
  Pulmonary Disease, Chronic Obstructive
  
• A Prospective Randomized Study Comparing High Dose Omeprazole Infusion Against Scheduled Second Endoscopy for Bleeding Peptic Ulcer
  ClinicalTrials.gov Identifier: NCT00164931 - Recruiting
  Peptic Ulcer Hemorrhage
  
• Does Omeprazole Decrease Intestinal Calcium Absorption?
  ClinicalTrials.gov Identifier: NCT00582972 - Not yet recruiting
  Osteoporosis; Achlorhydria; GERD; Hip Fracture
  
• Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
  ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
  Gastroparesis; Gastroesophageal Reflux Disease
  
• Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
  ClinicalTrials.gov Identifier: NCT00542347 - Recruiting
  Gastric Acid
  
• The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients with Hypersecretion of Gastric Acid
  ClinicalTrials.gov Identifier: NCT00001191 - Completed
  Gastrinoma; Zollinger Ellison Syndrome
  
• Lopinavir Capsules to Kaletra or Invirase Tablets
  ClinicalTrials.gov Identifier: NCT00438152 - Recruiting
  HIV Infections
  
• Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill
  ClinicalTrials.gov Identifier: NCT00045799 - Completed
  Upper gastrointestinal bleeding
  
• An Exploratory Study of NBI-34060 Capsules and Next Day Functioning
  ClinicalTrials.gov Identifier: NCT00525941 - Recruiting
  Insomnia
  
• Optimal Dose of Omeprazole After Endoscopic Treatment of Bleeding Peptic Ulcers
  ClinicalTrials.gov Identifier: NCT00519519 - Recruiting
  Bleeding Peptic Ulcers Disease
  
• Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
  ClinicalTrials.gov Identifier: NCT00002682 - Active, not recruiting
  mucosa-associated lymphoid tissue; stage I diffuse small lymphocytic/marginal zone lymphoma
  
• Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00532467 - Recruiting
  Healthy
  
• Itraconazole Tablets Vs. Itraconazole Capsules vs. Placebo in Onychomycosis of the Toenail.
  ClinicalTrials.gov Identifier: NCT00356915 - Active, not recruiting
  Onychomycosis of the Toenail
  
• A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent? Inhalation Aerosol in COPD Patients.
  ClinicalTrials.gov Identifier: NCT00359788 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• A Study of Paricalcitol Capsules on Reducing Albuminuria in Type 2 Diabetic Nephropathy Being Treated With Renin-Angiotensin System Inhibitors
  ClinicalTrials.gov Identifier: NCT00421733 - Recruiting
  Diabetic Nephropathies
  
• Evaluation of efficacy, safety and tolerability of Targretin capsules in patients with advanced or metastatic non-small cell lung cancer
  ClinicalTrials.gov Identifier: NCT00050973 - Active, not recruiting
  Non-small cell lung cancer
  
• A Study of Paclitaxel and Carboplatin in Combination with Bexarotene Oral Capsules in Patients with Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00153842 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• S-Adenosyl Methionine for Symptomatic Treatment of Primary Biliary Cirrhosis
  ClinicalTrials.gov Identifier: NCT00125281 - Recruiting
  
  
• Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma
  ClinicalTrials.gov Identifier: NCT00003151 - Active, not recruiting
  contiguous stage II diffuse small lymphocytic/marginal zone lymphoma; stage I diffuse small lymphocytic/marginal zone lymphoma
  
• Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secrectory Conversion
  ClinicalTrials.gov Identifier: NCT00160199 - Recruiting
  Secondary Amenorrhea
  
• Convenience, Tolerability, and Safety of Change in the Administration of Rivastigmine From Capsules to a Transdermal Patch in Patients With Mild to Moderate Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00549601 - Recruiting
  Alzheimer's Disease
  
• Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis
  ClinicalTrials.gov Identifier: NCT00450086 - Recruiting
  Collagenous Colitis
  
• A Phase 3, Randomized, Open-Label, Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice-Daily Administration, When Co-Administered With NRTIs in Antiretroviral Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00262522 - Active, not recruiting
  HIV Infection
  
• Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00120900 - Completed
  Osteoarthritis
  
• Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00257192 - Recruiting
  Schizophrenia
  
• Safety and Tolerability of Ziprasidone in Adolescents With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00265382 - Recruiting
  Schizophrenia
  
• A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
  ClinicalTrials.gov Identifier: NCT00281606 - Not yet recruiting
  HIV Infection
  
• Dental Pain (Following Third Molar Tooth Extraction) Study
  ClinicalTrials.gov Identifier: NCT00114049 - Completed
  Pain; Postoperative Pain
  
• Sopran - Omeprazole Treatment Versus Surgery
  ClinicalTrials.gov Identifier: NCT00256737 - Completed
  GERD
  
• Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00265330 - Recruiting
  Bipolar Disorder
  
• Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00523991 - Recruiting
  Pulmonary Disease, Chronic Obstructive
  
• The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year
  ClinicalTrials.gov Identifier: NCT00000848 - Completed
  HIV Infections
  
• Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
  ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
  Epilepsy
  
• The PRIMO Study-Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00497146 - Not yet recruiting
  Chronic Kidney Disease; Left Ventricular Hypertrophy
  
• A 12-Week Randomised, Double Blind, Placebo Controlled, Parallel Group Trial Evaluating the Efficacy and Safety of Inhaled Tiotropium 18µg q.d. in Patients with COPD and a Concomitant Diagnosis of Asthma
  ClinicalTrials.gov Identifier: NCT00152984 - Completed
  Pulmonary Disease, Chronic Obstructive; Asthma
  
• Healing Effects of Rebamipide and Omeprazole in Helicobacter Pylori-Positive Gastric Ulcer After Eradication Therapy
  ClinicalTrials.gov Identifier: NCT00272467 - Completed
  Stomach Ulcer
  
• Fish Oil for the Treatment of Depression in Patients with Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00122954 - Recruiting
  Multiple Sclerosis; Depression
  
• A Phase II Study of Tarceva and Targretin Oral Capsules in Patients with Advanced Advanced Lung Cancer
  ClinicalTrials.gov Identifier: NCT00125359 - Recruiting
  Carcinoma, Non-Small Cell Lung Cancer; Non-small cell lung cancer; NSCLC
  
• A Study to Investigate the Pharmacodynamic Effect After Four-Week Omeprazole Treatment of Non-Erosive Reflux Disease in a Japanese Population
  ClinicalTrials.gov Identifier: NCT00259051 - Completed
  Non-Erosive Reflux Disease
  
• Safety and Pharmacokinetic Study of BIO 300 Capsules
  ClinicalTrials.gov Identifier: NCT00504335 - Completed
  Acute Radiation Syndrome
  
• Four-Week Omeprazole Treatment of Non-Erosive Reflux Disease in a Japanese Population
  ClinicalTrials.gov Identifier: NCT00259077 - Completed
  Non-Erosive Reflux Disease
  
• A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
  ClinicalTrials.gov Identifier: NCT00463021 - Completed
  Secondary Hyperparathyroidism
  
• Tiotropium Inhalation Capsules and Atrovent MDI Comparison Trial in Taiwan
  ClinicalTrials.gov Identifier: NCT00274092 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00301236 - Completed
  ADHD, ADD
  
• Efficacy and Safety (Including 24-Hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD
  ClinicalTrials.gov Identifier: NCT00239460 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Bioavailability Of Flucloxacillin Capsules (250 Mg and 500 Mg)
  ClinicalTrials.gov Identifier: NCT00358371 - Completed
  Healthy
  
• Safety Study of SRX251 Capsules in Healthy Female Volunteers
  ClinicalTrials.gov Identifier: NCT00461370 - Completed
  Healthy
  
• A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
  ClinicalTrials.gov Identifier: NCT00067431 - Terminated
  Partial Seizure Disorder
  
• A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort
  ClinicalTrials.gov Identifier: NCT00268827 - Completed
  HIV-1; AIDS
  
• A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Sallmeterol Inhalation Aerosol.
  ClinicalTrials.gov Identifier: NCT00274560 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00343629 - Completed
  Unspecified Adult Solid Tumor, Protocol Specific
  
• A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis
  ClinicalTrials.gov Identifier: NCT00418600 - Completed
  Secondary Hyperparathyroidism
  
• Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)
  ClinicalTrials.gov Identifier: NCT00442741 - Terminated
  Solid Tumors
  
• A Study to Assess the Efficacy, Safety and Tolerability of Tegaserod Alone and in Combination with Omeprazole Given Orally in Patients with Symptoms of Symptomatic Gastroespohageal Reflux Disease (sGERD)
  ClinicalTrials.gov Identifier: NCT00149851 - Completed
  symptomatic gastroespohageal reflux disease
  
• Treatment of Partial Seizures in Children
  ClinicalTrials.gov Identifier: NCT00102713 - Completed
  Epilepsies, Partial
  
• The Safety and Effectiveness of Saquinavir Soft Gelatin Capsules Combined with Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002425 - Completed
  HIV Infections
  
• A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00002383 - Completed
  HIV Infections
  
• A Study of Saquinavir Soft Gelatin Capsules Combined with Other Anti-HIV Drugs in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00002374 - Completed
  HIV Infections
  
• An Open-Label Extension to Evaluate the Efficacy and Safety of Rivastigmine Capsules in Patients with Probable Vascular Dementia
  ClinicalTrials.gov Identifier: NCT00130338 - Completed
  Vascular Dementia
  
• Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
  ClinicalTrials.gov Identifier: NCT00257166 - Completed
  Bipolar Disorder
  
• A Study of Targretin Capsules in Patients with AIDS-Related Kaposi's Sarcoma
  ClinicalTrials.gov Identifier: NCT00002212 - Completed
  Sarcoma, Kaposi; HIV Infections
  
• Efficacy and Safety of Rivastigmine Capsules in Patients with Probable Vascular Dementia
  ClinicalTrials.gov Identifier: NCT00099216 - Completed
  Vascular Dementia
  
• A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00002378 - Completed
  HIV Infections
  
• A Study of Saquinavir Soft Gel Capsules (SGC) Used in Combination With Two Other Anti-HIV Drugs in Patients with HIV-Associated Kidney Disease
  ClinicalTrials.gov Identifier: NCT00002397 - Completed
  HIV Infections; AIDS-Associated Nephropathy
  
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002367 - Completed
  HIV Infections
  
• Effects of Lutein in retinitis pigmentosa
  ClinicalTrials.gov Identifier: NCT00029289 - Completed
  Retinitis Pigmentosa
  
• Randomized Study of Pancrelipase With Bicarbonate (PANCRECARB) Capsules in Reducing Steatorrhea in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00006063 - Completed
  Cystic Fibrosis
  
• A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00239434 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• A Randomized, Double Blind, Placebo Controlled Trial to Compare the Effect of Tiotropium Inhalation Capsules (Spiriva, Bromuro De Tiotropio) on Exercise Tolerance in Patients with COPD Participating in 8 Weeks of Pulmonary Rehabilitation
  ClinicalTrials.gov Identifier: NCT00157235 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
  ClinicalTrials.gov Identifier: NCT00002047 - Completed
  HIV Infections; Kidney Failure, Chronic
  
• A Study Investigating Pancrelipase Delayed Release Capsules in Patients With Exocrine Pancreatic Insufficiency
  ClinicalTrials.gov Identifier: NCT00414908 - Suspended
  Pancreatic Insufficiency
  
• A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Vs. Immediate Release Carbidopa/Levodopa
  ClinicalTrials.gov Identifier: NCT00134966 - Completed
  Parkinson''s Disease
  
• A Randomised, Double-Blind, Placebo-Controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients with Chronic Obstructive Pulmonary Disease (COPD).
  ClinicalTrials.gov Identifier: NCT00144326 - Completed
  Pulmonary Disease, Chronic Obstructive
  
• A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or Histoplasmosis
  ClinicalTrials.gov Identifier: NCT00002159 - Completed
  HIV Infections; Histoplasmosis; Blastomycosis
  
• Comparison of safety and efficacy of tizanidine hydrochloride capsules versus Zanaflex® (tizanidine hydrochloride tablets) taken while in the fed state (just after a meal) and in the fasted state (before a meal) in patients with moderate to severe sp
  ClinicalTrials.gov Identifier: NCT00047580 - Completed
  Multiple Sclerosis; Muscle Spasticity; Spinal Cord Injury; Stroke